Skip to main content Accessibility help
×
Home
Instructions for contributors

Introduction

European Psychiatry is the official journal of the European Psychiatric Association, the largest international association of psychiatrists in Europe. The purpose of the EPA is to improve the lives of patients with psychiatric disorders and to promote professional excellence through education and research. European Psychiatry supports the mission of the EPA and publishes articles on topics relevant to all mental health clinicians, researchers, and neuroscientists.

European Psychiatry publishes one continuous Open Access volume annually with articles on original research on pre-clinical and clinical scientific fields investigating the aetiology, pathophysiology and treatment of psychiatric disorders. European Psychiatry accepts publications originating from any part of the world based only on their scientific merit. All articles are published in English. The quality of the language is of paramount importance as it influences how the manuscript is received by Editors, reviewers and readers. For authors who are not English speakers and may not be experienced in scientific writing in English we strongly recommend the use of appropriate language services.

Types of article

Types of accepted articles and their specifications are given below. Word count for the main manuscript includes only the main body of text (i.e., not tables, figures, abstracts or references). All pages should be numbered. Manuscripts should be double-spaced. All abbreviations (other than those for units of measure) should be spelled out the first time they are used anywhere in the manuscript. Idiosyncratic abbreviations should not be used.

Research Articles

Abstract no longer than 250 words, structured as follows: Background, Methods, Results, Conclusions

Main text should not exceed 3,500 words, with the following structure: Introduction, Methods, Results, Discussion. There is no limit on the number of figures, tables, or references.

Reviews / Meta-Analyses

Abstract no longer than 250 words, structured as follows: Background, Methods, Results, Conclusions

Main text should not exceed 4,000 words, with the following structure: Introduction, Methods, Results, Discussion. There is no limit to figures, tables, or references.

Editorials

Editorials may only be authored by the Editors or by authors invited by the Editors or proposed by the EPA board. No unsolicited editorial will be accepted. An editorial cannot exceed 1,000 words, with no more than 10 references and one table or figure. Editorials will not be subject to peer review. Authors will be expected to uphold standards of civility and professionalism in presenting their views. Editorials are required to cover topics on mental health policy and related topics, in accordance with the aim of the European Psychiatric Association.

Viewpoint

Viewpoint articles may be submitted by any author. These may address important topics in psychiatry, public health or health policy, research, ethics, or health law. Viewpoints are not required to be linked to a specific article in European Psychiatry.

Viewpoints cannot exceed 1,500 words and 10 references, and may include no more than one figure or one table.

Viewpoints should be tightly focused on the topic they cover, and scholarly; in other words, viewpoints cannot rely on personal or idiosyncratic views unsupported by evidence. Viewpoints will be subjected to editorial review to ensure they meet these basic criteria, followed by peer-review.

EPA Position Papers

EPA position papers may only be submitted by authors of the EPA board or by authors commissioned by the EPA board, and address any topic in psychiatry, public health or health policy, research, ethics, or health law that is important to the mission of the EPA. EPA position papers cannot exceed 3500 words and should include an unstructured abstract that cannot exceed 250 words. Figures and tables should be limited to five each; references to 75. Position papers should be tightly focused on the topic they cover, and scholarly. Position papers will be peer-reviewed after being endorsed by the EPA board.

EPA Guidance Papers

EPA Guidance Papers aim to improve the quality of mental health care in Europe by disseminating written information based on best evidence and psychiatric practice and to facilitate countries learning from each other in areas where guidelines are lacking.

EPA Guidance Papers are commissioned by the EPA Board and are written by experts in their field.

EPA Guidance Papers cannot exceed 3,500 words and should include an unstructured abstract that cannot exceed 250 words. Figures and tables should be limited to five each; references to 75. Guidance papers will be approved by the EPA Board and will be subjected to peer-review.

Comments

Comments can be made on any article published by the journal. They cannot exceed 750 words, with no more than five references. These are not submitted through the peer-review system but through the 'Comments' section of the article web-page on Cambridge Core. Comments will not be subject to peer review in order to enable the free exchange of ideas, though will be moderated by the Editors. Authors will be expected to uphold standards of civility and professionalism in presenting their comments, particularly if critical.

European Psychiatry no longer accepts case reports or case series and no longer routinely considers manuscripts on the psychometric properties, standardisation, translation or transcultural validation of psychiatric questionnaires, instruments or cognitive tests.

Submitting your manuscript

Before submitting your manuscript, please ensure that you carefully read and adhere to all the guidelines and instructions to authors provided below. Manuscripts not conforming to these guidelines may be returned. Submission of an article implies that the work described has not been published previously, and that it is not currently being considered by another journal. Authors must also confirm that each author has seen and approved the contents of the submitted manuscript.

All material to be considered for publication should be submitted via the online submission system. Queries outside of direct submission can be submitted to the Editor at EPJournal@cambridge.org.

Please note that APC waiver requests should be submitted to the publisher prior to submission.

Peer review policy: European Psychiatry uses a single blind review process, with each paper being peer reviewed by 2-3 reviewers. After an editorial decision is made, an email containing the comments from the reviewers and the editor will be sent to the author.

Acceptable file types: Only electronic files conforming to the journal's guidelines will be accepted. Preferred formats for the text and tables of your manuscript are Word DOC, RTF, and XLS. Please do not submit tables as image files. Please also refer to additional guidelines on submitting artwork below.

Artwork, figures and other graphics: All figures and tables should be supplied in separate files, with tables supplied as editable files only. Resolution: halftone images must be saved at 300 dpi at approximately the final size. Line drawings should be saved at 1000 dpi, or 1200 dpi if very fine line weights have been used. Combination figures must be saved at a minimum of 600 dpi. Cambridge recommends that only TIFF, EPS, or PDF formats are used for electronic artwork. For more detailed guidance on the preparation of illustrations, pictures and graphs in electronic format please see the Cambridge Journals Artwork Guide.

Manuscript preparation

Language: Cambridge recommends that authors have their manuscripts checked by an English language native speaker before submission; this will ensure that submissions are judged at peer review exclusively on academic merit. Cambridge University Press partners with American Journal Experts to provide a high quality service to authors. More information can be found here. Use of this service is entirely voluntary and does not guarantee acceptance, nor does its use require authors to later submit to a Cambridge journal.

Papers can be submitted in either American or British English.

All papers submitted must contain line numbers.

Authorship: Although discretion is allowed, authors should fulfil the criteria set out by the International Committee of Medical Journal Editors (http://www.icmje.org). The ICMJE recommends that authorship be based on the following 4 criteria:

  • Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  • Drafting the work or revising it critically for important intellectual content; AND
  • Final approval of the version to be published; AND
  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

The contribution of individuals who were involved in the study, but do not meet these criteria should be acknowledged in the Acknowledgments section. Addition of authors post acceptance is not guaranteed and will be at the discretion of the Editor.

Author contact details: Provide full contact details for the corresponding author including email and mailing address. Full author names and academic affiliations are required for all co-authors.

Title page:

The title page must include:

  • The title of the article, which should be concise but informative
  • Initials and last name of author (or appropriate style)
  • Name of department(s) and institution(s) to which the work should be attributed
  • Name, mailing address and email address of author responsible for correspondence about the manuscript
  • A shortened version of the title consisting of no less than 45 characters (including spaces)

Abstract: Each paper must contain an abstract as detailed in the 'Types of Paper' section.

Keywords: Each manuscript should be accompanied by 3-5 relevant keywords.

Acknowledgements: Any acknowledgements should appear first at the end of your article prior to your Conflicts of Interest declaration, any footnotes, and your References. You may acknowledge individuals or organisations that provided advice and support (non-financial). Formal financial support and funding should be listed in the following section.

Financial Support: Please provide details of the sources of financial support for all authors, including grant numbers. For example, "This work was supported by the Medical Research Council (grant number XXXXXXX)". Multiple grant numbers should be separated by a comma and space, and where research was funded by more than one agency the different agencies should be separated by a semi-colon, with "and" before the final funder. Grants held by different authors should be identified as belonging to individual authors by the authors' initials. For example, "This work was supported by the Wellcome Trust (A.B., grant numbers XXXX, YYYY), (C.D., grant number ZZZZ); the Natural Environment Research Council (E.F., grant number FFFF); and the National Institutes of Health (A.B., grant number GGGG), (E.F., grant number HHHH). Where no specific funding has been provided for research, please provide the following statement: "This research received no specific grant from any funding agency, commercial or not-for-profit sectors."

Conflicts of Interest:

Authors should include a Conflicts of Interest declaration in their manuscript. Authors should title this declaration "Conflicts of Interest", and should place this declaration at the end of the text of their manuscript before the References are listed. If authors do not include this declaration, their submission will not proceed to peer review.

Conflicts of Interest are situations that could be perceived to exert an undue influence on an author's presentation of their work. They may include, but are not limited to, financial, professional, contractual or personal relationships or situations. Authors should use the disclosure form of the International Committee of Medical Journal Editors (ICMJE) to generate the disclosure sentence they should include in their manuscripts. Authors should then save their completed ICMJE form for their own record.

If the manuscript has multiple authors, the author submitting the manuscript must include Conflicts of Interest declarations relevant to all contributing authors.

Example wording for a Conflicts of Interest declaration is as follows: "Conflicts of Interest: Author A is employed at company B. Author C owns shares in company D, is on the Board of company E and is a member of organisation F. Author G has received grants from company H." If no Conflicts of Interest exist, the declaration should state "Conflicts of Interest: Author A and Author B declare none".

Supplementary Material: If the author has material that may be useful to the reader, but not essential to understanding the article, this can be supplied as supplementary material. Supplementary materials are peer reviewed but will not be copyedited or typeset, so they should be supplied exactly as they are to appear online — care should be taken to make them as comprehensible as possible. The supplementary material should be supplied as a separate file, and should be referenced in the article. Types of supplementary material include, but are not limited to, images, videos, podcasts, and slideshows. A statement should be added after the Conflicts of Interest statement to read:

Supplementary Material
For supplementary material accompanying this paper, visit cambridge.org/EPA.

The link will be replaced by your article’s DOI during the production process.

References:

References are in Vancouver format (International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Fifth Edition. N Engl J Med 1997;336:309-16). In the text, references should appear as numbers between square brackets based on the order of citation. Indicate references by number(s) in square brackets in line with the text. The actual authors can be referred to, but the reference number(s) must always be given.

At the end of the manuscript, all references should be listed in numerical order corresponding to the order of citation in the text. Authors are responsible for the accuracy of their references. All references cited in the text should be listed and all listed references should appear next to the corresponding text. References in tables and figures should also be numbered. The names of the journals should be abbreviated according to those used in the latest edition of Index Medicus. The volume, issue and first and last pages should be included. Abstracts should be marked as such. Papers that have been submitted or accepted but are not available online should not be cited. Papers in preparation should not be cited. References should include a DOI whenever possible, in the format http://doi.org/....

Examples follow. Please note the shortened form for the last page number (e.g., 51–9), and that for more than six authors the first six should be listed followed by 'et al.':

Reference to a journal publication:

[1] Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci Commun. 2010;163: 51–9. https://doi.org/10.1016/j.Sc.2010.00372.

Reference to a journal publication with an article number:

[2] Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. Heliyon. 2018;19: e00205. https://doi.org/10.1016/j.heliyon.2018.e00205

Reference to a book:

[3] Strunk Jr W, White EB. The elements of style. 4th ed. New York: Longman; 2000.

Reference to a chapter in an edited book:

[4] Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith RZ, editors. Introduction to the electronic age, New York: E-Publishing Inc; 2009, p. 281–304.

Reference to a website:

[5] Cancer Research UK. Cancer statistics reports for the UK, http://www.cancerresearchuk.org/aboutcancer/statistics/cancerstatsreport/; 2003 [accessed 13 March 2003].

Reference to a dataset:

[6] Koopman B, Zuccon G. A test collection for matching patient to clinical trials: V2; 2016 [Data file]. http://doi.org/10.4225/08/574CE878156EE

After acceptance

Accepted Manuscripts: Accepted Manuscripts are published online (before copyediting or typesetting) within approximately a week of final acceptance, provided Cambridge have received all final files and a completed License to Publish form. At this point, the article will be assigned its final DOI and be considered published and citable. The corresponding author will subsequently receive a proof of your typeset, edited article, which will eventually replace the accepted manuscript online and be considered the final Version of Record. For more information, please click here.

First proofs: First proofs will be emailed to the corresponding author after acceptance. Contributors should ensure that they are available to check their first proofs and answer any queries that have arisen during copyediting and typesetting.

Supplying corrections: Authors should mark up the corrections to their article by using the online proofing interface. Full details on how to send corrections will be given in the first proof email. Please note that it is the author's responsibility to check the proof carefully; errors not found may appear in the published article. Authors will receive a link to the PDF of their final article, along with a shareable link.

For more details on the Cambridge production process see the comprehensive set of FAQs.

Open Access

All articles published by European Psychiatry are made freely and permanently accessible online immediately upon publication under an Open Access Creative Commons license. Authors must complete and return a licence to publish form once their article has been accepted for publication.

To ensure availability of funding has no bearing on editorial decisions, the Editors of European Psychiatry are never involved in correspondence with authors on payment of publication charges. Please submit all APC waiver request directly to the publisher prior to submission.

Click here for additional information on Open Access publishing within European Psychiatry. For more information about Open Access at Cambridge University Press, see our Cambridge Open pages.

Copyright and licensing

Articles will be published under a Creative Commons Attribution licence (CC-BY) as standard, but authors may elect to publish under the following alternative licences:

  • CC-BY-NC-SA (Attribution - Non-Commercial - Share Alike)
  • CC-BY-NC-ND (Attribution - Non-Commercial - No Derivatives)

For information on what each licence allows, please visit creativecommons.org/licenses

Transparency and Openness Guideline

European Psychiatry believes that research articles should contain sufficient information to allow others to understand, verify, and replicate findings. We therefore believe that whenever possible, authors should make evidence and resources that underpin published findings available to readers without undue barriers to access, and under licences that freely permit reuse.

How to comply with this guideline

If you have made your resources publicly available, for example through a repository, a Data Availability Statement in your manuscript should state where and how they may be accessed.

"Data" is interpreted in the broadest sense to mean any evidence or resources that would be necessary for others to fully evaluate the basis for your findings, and to verify or reproduce your work. This includes raw or processed data sets, code, and protocols, as well as qualitative resources such as images, audio, video, maps, interview transcripts, field notes, and public reports. It also includes any information necessary for others to access, interpret and process these resources.

Some examples of Data Availability Statements are given below:

  • The data that support the findings of this study are openly available in [repository name] at http://doi.org/[doi], reference number [reference number].
  • The data that support the findings will be available in [repository name] at [URL / DOI link] following a [6 month] embargo from the date of publication to allow for commercialisation of research findings.
  • The data that support the findings of this study are available from [third party]. Restrictions apply to the availability of these data, which were used under licence for this study. Data are available [from the authors / at URL] with the permission of [third party].

How to share resources

European Psychiatry encourages the sharing of resources through repositories that make content as Findable, Accessible, Interoperable and Reusable (FAIR) as possible. Wherever possible, authors are encouraged to use repositories that:

  • Are committed to the long-term preservation and accessibility of their content.
  • Are supported and recognised by the community as appropriate for the resources they hold.
  • Provide stable, unique identifiers for the information they hold.
  • Support linking between their database records and associated published research articles.
  • Allow free public access to their holdings, with reasonable exceptions (such as administration charges for the distribution of physical materials).

If necessary, resources may also be shared as supplementary material.

If there are domain-specific, specialised repositories in common use in your research community, we recommend using those to share resources. Generalist repositories, which can host a wide variety of data types, may also be used if no appropriate specialised repository exists. Examples of general repositories include Zenodo, Figshare, Dataverse, Dryad, and the Open Science Framework. Guidance for preparing qualitative data for sharing is provided by bodies such as the Qualitative Data Repository and ICPSR.

For any questions about this guideline, please contact the editorial office.

ORCiD

ORCiD provides a unique identifier for researchers and, through integration in key research workflows such as publication and grant applications, provides the following benefits:

  • Discoverability: ORCiD increases the discoverability of your publications, by enabling smarter publisher systems and by helping readers to reliably find work that you've authored.
  • Convenience: As more organisations use ORCiD, providing your ID or using it to register for services will automatically link activities to your ORCiD profile, and will save you re-keying information multiple times.
  • Keeping track: Your ORCiD profile is a neat place to record and display (if you choose) validated information about your research activities.

If you don't already have an ID, you'll need to create one if you decide to submit a manuscript to the journal. You can register for one directly from your user account on Editorial Manager or via https://orcid.org/register. If you already have an ID, please use this when submitting by linking it to your ScholarOne user account. Simply log in to your account using your normal username and password. Edit your account by clicking on your name at the top right of the screen and from the dropdown menu, select 'E-Mail / Name'. Follow the instructions at the top of the screen to update your account.

A list of FAQ about Cambridge University Press's use of ORCiD can be found here. Answers to technical questions relating to how the ORCiD system works can be found here: https://orcid.org/help

Other information

Ethical Standards: European Psychiatry adheres to the Committee on Publication Ethics (COPE) guidelines on research and publications ethics.

Where research involves human and/or animal experimentation, the following statements should be included (as applicable) in the Methods section: "The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008." and "The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional guides on the care and use of laboratory animals." Articles reporting randomised trials must conform to the standards set by the Consolidated Standards of Reporting Trials (CONSORT) consortium. Authors are also required to abide by the ICMJE guidelines regarding informed consent.

European Psychiatry and Cambridge University Press take issues of copyright infringement, plagiarism, or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of articles published in the journal. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked using duplication-checking software. Where an article is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article (removing it from the journal); taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; banning the author from publication in the journal, or appropriate legal action.

For further information on Cambridge's Ethical Guidelines, please visit these pages: Publication Ethics and Ethical Standards.

Clinical trials: As a condition of consideration for publication, registration of clinical trials in a public trials registry is required. A clinical trial is defined by the International Committee of Medical Journal Editors (in accordance with the definition of the World Health Organisation) as any research project that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Registration information must be provided at the time of submission, including the trial registry name, registration identification number, and the URL for the registry.

Continuous publication: European Psychiatry benefits from a continuous publication format. Completed articles are assigned an e-number and are published in an open volume, closed at the end of each year. Once an article has been published online, it is considered to be in its final format and no changes can be made.

Neuroscience Peer Review Consortium (NPRC): European Psychiatry participates in the Neuroscience Peer Review Consortium — a cross-publisher alliance of neuroscience-related journals that accept manuscript reviews from other NPRC journals. If a manuscript is not accepted by one journal in the NPRC, the authors have the option to submit their manuscript to a second NPRC journal and have the reviews from the first journal forwarded to the second journal, reducing work and duplication of effort for authors, reviewers, and editors.

This is entirely optional for authors, and editors receiving such prior reviews will use them at their discretion. For more information about the NPRC and the process involved please visit the website here: http://nprc.incf.org/index.php/about/information-for-authors/

Digital preservation policy: Cambridge University Press publications are deposited in the following digital archives to guarantee long-term digital preservation:

  • CLOCKSS (journals)
  • Portico (journals and books)

Further information: Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Editor at EPJournal@cambridge.org


Last updated: July 2019